CEFPROZIL
- Product NDC
- 68180-273
- 11-digit product format
- 681800273
- Labeler code
- 68180
- Product ID
- 68180-273_f2cfb43d-9704-49ca-8eae-97327e62044d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cefprozil
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA065261
- Marketing category
- ANDA
- Marketing start
- 2026-05-04
- Substance
- CEFPROZIL
- Active strength
- 250 mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CEFPROZIL
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFPROZIL | 250 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4W0459ZA4V |
| Rxcui | 309081 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68180-273-01 | CEFPROZIL | 50 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 50 | | 1 |
| 68180-273-02 | CEFPROZIL | 75 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 75 | | 1 |
| 68180-273-03 | CEFPROZIL | 100 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 100 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68180-273-01 | 68180027301 | 50 mL in 1 BOTTLE (68180-273-01) | 50 ml | 2026-05-04 | No | No | Current |
| 68180-273-02 | 68180027302 | 75 mL in 1 BOTTLE (68180-273-02) | 75 ml | 2026-05-04 | No | No | Current |
| 68180-273-03 | 68180027303 | 100 mL in 1 BOTTLE (68180-273-03) | 100 ml | 2026-05-04 | No | No | Current |